key: cord-0772642-poops47f authors: Khan, Rao; Darafsheh, Arash; Goharian, Mehran; Cilla, Savino; Eduardo Villarreal-Barajas, J. title: Evolution of clinical radiotherapy physics practice under COVID-19 constraints date: 2020-05-29 journal: Radiother Oncol DOI: 10.1016/j.radonc.2020.05.034 sha: f2bcc1b066cb3e9d0d21ebef2b31c08c81fad9e0 doc_id: 772642 cord_uid: poops47f As the COVID-19 spread continues to challenge the societal and professional norms, radiotherapy around the globe is pushed into an unprecedented transformation. We will discuss how clinical physics has transformed to ascertain safety and quality standards across four facilities around the world through diversity of action, innovation, and scientific flexibility. As the COVID-19 spread continues to challenge the societal and professional norms, radiotherapy around the globe is pushed into an unprecedented transformation. We will discuss how clinical physics has transformed to ascertain safety and quality standards across four facilities around the world through diversity of action, innovation, and scientific flexibility. The COVID-19 pandemic, caused by the SARS-CoV-2 virus, has led to over 3.8 million confirmed infections and 265,000 deaths globally [1] . As of now, any specific treatment or vaccine is lagging behind the rapid spread of this contagious illness. The aerosol and fomite transmission of the agent is likely and the experimental studies have demonstrated that the SARS-CoV-2 can survive several hours in air (and up to several days on certain surfaces) [2] ; hence the natural course of action against the disease is to avoid exposure from the respiratory secretions of an infected individual [3] . In order to slow down spread of the disease, WHO and various national health agencies recommend physical distancing of 2 m between individuals which is being implemented as "socialdistancing" in various parts of the world. This very benign advice has caused mayhem in all walks of modern life. From Asia to the Americas, almost everywhere, states, and jurisdictions have imposed restrictions on non-essential contact by issuing stay-at-home, or lock-down orders. In hospitals, including radiation oncology facilities, prevention and control measures are in place to ensure safety of the cancer patients, health professionals and caregivers, and to manage treatment of suspected or COVID-19 positive cancer patients. Clinical workflow and contingency measures from several radiation therapy (RT) departments are now part of the emerging literature [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Several individuals and organizations, such as ASTRO and ESTRO, have published opinions, recommendations and guidelines on RT management of cancer patients, such as for head and neck [19, 20] , lung [21] , breast [22] , gastrointestinal [23] , gynecological [24] , rectum [25] , prostate [26] , and emergency palliative care [27] . Medical physicists across the world provide supporting roles in RT including administration, direct clinical services, equipment performance evaluation, quality assurance, safety, informatics, education and training, research, and service development [28, 29] . In order to execute these tasks safely and efficiently, they have to operate in teams, supervise staff, provide consultation and in some activities face-to-face patient interactions. Although the philosophy behind clinical physics operations is similar, various tasks can be accomplished in different order or under different constraints arising from organizational culture and operational environment. Under various constraints of social distancing, one important question commonly asked is: "how much quality assurance (QA) is enough?" Since the COVID-19 outbreak, there has been a sudden transformation of clinical physics tasks with no historical precedent, it is therefore prudent to review and document how the practice patterns have changed in different parts of the world [18] . The majority of emerging literature lacks details of how various clinical physics workflow and operations have adapted to the new realities. Therefore, in this work, we will provide a snapshot of common radiotherapy physics workflow across a geographical sample of clinics in North America and Europe with the aim that it will provide supporting data to develop some consensus through diversity of approaches. These clinics operate under various fiscal models, human resources, societal norms, and other healthcare constraints. Four variable sized, geographically distributed, cancer clinics A (St. Louis, MO, USA), B (Victoria BC, Canada), C (Exeter, Devon, UK) and D (Campobasso, Italy) were included in this study. Figure 1 General radiotherapy process and clinical physics roles. The process elements are adaptable for stereotactic body radiotherapy (SBRT), high dose rate (HDR), low dose rate (LDR) brachytherapy, stereotactic radiosurgery, (SRS) and 3D conformal radiotherapy (3D-CRT). A summary of clinical physics practice patterns for the four radiotherapy facilities both prior to and during the outbreak is provided in Table 1 , where tasks are allocated to those able to be carried out remotely or those needing the physical presence in the clinic of a physicist. The study was restricted to the most common tasks performed by at least three of the participating institutions, other specialized tasks for total body irradiation (TBI), MRgRT, proton therapy etc., were not included in the comparison. All remote All remotely except, patientspecific delivery QA All remotely except first fraction patient setup and patient specific delivery QA All remotely except for simulation and delivery** HDR: All remote except the delivery ** LDR: ultrasound simulation, seeds QA, delivery in person; rest are done remotely For IMRT and VMAT QA, clinic B uses an in-house Monte Carlo-based independent dose calculation software or occasional portal dosimetry measurements. Clinic B continued to perform on-site initial modulated plan consultation and for single fraction treatments. Clinic C does not perform single fraction SRS treatments. Clinic D physics staff also does treatment planning for modulated and hypofractionated treatments. Single fraction treatments are planned by physicists at D; Gammaknife ® SRS treatments at clinic A are planned by a physicist. Clinic D does not perform any of the brachytherapy procedures listed above. In order to avoid possible spread of the contagion, the physics staffing was split into two teams: on-site and remote; their roles would be exchanged on a weekly basis or between early and late shift. Each team member was selected based on their ability to perform a variety of procedures. The site team practiced physical distancing, and used appropriate personnel protective equipment (PPE) when called to a procedure room. In response to the pandemic, the medical physics tasks were prioritized into essential tasks and non-urgent tasks that can tolerate delays and postponement (e.g., annual QA). Patient-specific QA, equipment QA, and commissioning of equipment and safety checks following relevant maintenance interventions were prioritized. The QA activities were moved to after-hours or weekends where possible such as therapy equipment calibration, machine QA and testing. Followed by the QA measurements, appropriate disinfecting protocols were adopted to avoid possible contamination of the treatment equipment. In case of clinic D, patient-specific QAs were performed early in the morning, prior to the start of treatments. The radiotherapy planning and management systems were set up for remote working; in two institutions the information technology (IT) infrastructure was cloud-based, while in others, planning desktops and other computers were accessed through a remote desktop application. Remote physics operations at institution A were initiated on March 16. This involved all administration and treatment planning dosimetrists to operate fully remotely, whereas physicists were split into on-site and remote teams. Telecommuting has continued unabated since then. The average fractions treated per day dropped by about 20% since COVID-19 impacted operations began. The physicians changed some plans to hypofractionated regimens, which lead to surge in plan complexity and workload for about one week. Due to a sufficient number of staff, the workload was manageable. One week into the outbreak, two linacs were shut down to have backup therapists in order to overcome any shortage of staff due to disease or other issues and also to use the rooms for possible COVID19+ radiotherapy. At institution B, one major advantage was using an in-house Monte Carlo-based independent dose calculation for IMRT/VMAT patient specific QA (if measurement is required it was performed using EPID dosimetry afterhours) which further helped with telecommuting. At institution C, telecommuting operations started the week of the March 23, which coincided with the beginning of general lockdown measures in the UK, and then was expanded to administrative and all treatment planning staff. Breast and prostate treatments were converted to hypofractionation with a general trend to hypofractionate other sites (sarcomas, rectum, etc.) where possible. New starts for prostates were initially put on hold, later they were resumed with various hypofractionated regimens (36 Gy in 5 fx or 60 Gy in 20 fx). All prostate HDR and radioiodines for thyroids were delayed indefinitely; only HDR treatments were allowed for the gynecological sites. The reduction from 15 fractions (for 40 Gy prescription) to 5 fractions (36 Gy prescription) for most breast treatments was the major contributor to the overall reduction of the total patient workload. The modified operations at institution D started on March 2, 2020, and the radiotherapy schedules rapidly moved towards hypofractionation. Since Clinic D was the only regional hospital providing radiotherapy, one of the major objectives was to maintain full access to radiation treatment even under emergency. The number of daily treatment slots were not decreased. Instead, by rearranging the work shifts and extending the treatment day by extra three hours, spatial and temporal distancing between patients and staff was ascertained. Since Italy was the first European country to witness a widespread outbreak of the coronavirus, the government decreed increased restrictions within lockdown areas/ "red zones", which were later extended to the whole nation on March 8, 2020. The Italian Association of Medical Physics (AIFM) [30] , following the suggestions of the European Federation of Medical Physics Organizations (EFOMP) [31] issued directives for the medical physics units operating in hospitals, with the aim to keep treatment and diagnostic procedures as safe as possible. Being a small physics group, to ensure social distancing, all on-site physics personnel operated in separated areas and rooms, while one physicist remotely worked from home (WFH) using web-conferencing and on-line meeting tools. In the absence of professional guidelines on clinical physics tasks during COVID-19, the goal of this short study was to understand adaptation of medical physics operations in various environments, learn from mutual experience and help develop some consensus on elasticity of physics tasks. The healthcare system in the United States is mostly privately owned and operated, unlike public or universal healthcare systems of Canada, United Kingdom and Italy. This can lead to different approaches from higher management when it comes to crisis management. The major objective of moving to a partially remote model was to provide unhindered safe clinical support for radiotherapy of cancer patients, should some of the physics staff become unavailable from infection or other need to isolate. It may be noted that similar solutions were adopted in reference [18] , which presented specific discussion of medical physics issues for COVID-19 operation of radiotherapy services in an Australasian context. One of the challenges at institution A was rationing and limited supply of PPE for the physics staff. After about one month of remote operations, WFH has been stressful for the physics team due to lack of interpersonal communication, face-to-face interactions, bonding and inclusion, though modern communication channels have provided some mitigation [32] . Due to restrictions on international travel, border closures, and supply-chain issues, mobility of goods and RT supplies has become uncertain. Radioactive 125 I seeds treatments can suffer greatly due to these disruptions resulting in potential cancelation of LDR procedures. There are some positive spinoffs of the COVID-19 work challenge. The institutional IT departments had to prioritize the implementation of WFH schemes, resistance to paperless initiatives dropped, hypofractionated approaches were implemented for breast and prostate radiotherapy as well as other sites with concurrent gains in time-efficiencies and possibly with equivalent or better outcomes. During the COVID-19 constrained situation a sense of closer working partnership between physicians, RTTs, other technical staff, administrative support and medical physicists has been developing. However, the significant perturbations that the COVID-19 response has caused in terms of delaying radiotherapy, and scaling down of operations (~ 25%) will create a backlog of patients that will challenge the effective and timely provision of radiotherapy in the very near future. It is critical to prepare for this reckoning, one can hope that the gains of workforce flexibility, telecommuting schemes and hypofractionation-derived efficiencies can counterbalance an impending increased demand for radiotherapy in post COVID-19 era. In addition, any postponed equipment servicing or preventative maintenance will also have to be rescheduled. Another major challenge especially with smaller operations like clinic D in the current study, was the smaller number of staff which made it difficult to operate as two completely independent groups. The staff reorganization was done to avoid any aggregation of personnel while guaranteeing the availability of staff and vital resources for the continuity of care. Though prioritizing of physics tasks in this work was done heuristically and in order to react speedily to the developing crisis, it may be more appropriate to deploy a systematic reliability engineering approach such as an institution-specific failure modes and effect analysis (FMEA) [33] to perform risk analysis for prioritizing QA tasks. There is also an imminent need for a professional medical physics task force to develop consensus on clinical physics tasks under a pandemic or major catastrophe. Only a consensus can address the amount of QA, preferred order of operations and other relevant questions. While we acknowledge that providing recommendations during the spread of pandemic is challenging due to lack of data points and the changing nature of the spread, sharing the commonalities and contrasts of our experiences across these four cancer clinics operating under different healthcare norms, along with those from [18] , could lead to consensus among the physics community. An interactive web-based dashboard to track COVID-19 in real time Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster Radiotherapy Workflow and Protection Procedures During the Coronavirus Disease 2019 (COVID-19) Outbreak: Experience of the Hubei Cancer Hospital in Wuhan, China Navigating the challenges of the COVID-19 outbreak: perspectives from theradiation oncology service in Singapore Novel Coronavirus International Public Health Emergency: Guidance on Radiation Oncology Facility Operation Contingency plans in a radiation oncology department amid the 2019-nCoV outbreak in Switzerland An Integrated Program in a Pandemic: Johns Hopkins Radiation Oncology Department COVID-19 outbreak in northern italy: first practical indications for radiotherapy departments How should we implement radiotherapy for cancer patients in China during the endemic period of COVID-19? Covid-19 outbreak in a major radiation oncology department; which lessons should be taken? Bracing for impact with new 4R's in the COVID-19 pandemic-a provincial thoracic radiation oncology consensus A rapid review of evidence and recommendations from the SIOPE Radiation Oncology working group to help mitigate for reduced paediatric radiotherapy capacity during the COVID-19 pandemic or other crises Implications for cancer care in Iran during COVID-19 pandemic Radiotherapy imaging: an unexpected ally in fighting COVID 19 pandemic Prevention and control measure to avoid cross infection during radiotherapy in coronavirus disease 2019 (COVID-19) epidemic in Wuhan, China Cancer patients in covid-19 era: swimming against the tide COVID-19 pandemic planning: considerations for radiation oncology medical physics Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement The impact of Coronavirus (COVID-19) on head and neck cancer patients' care Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement Breast radiotherapy under COVID-19 pandemic resource constraints -approaches to defer or shorten treatment from a Comprehensive Cancer Center in the United States Recommendations on the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19 COVID-19 and gynecological cancers: A Moroccan point-of-view International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19 Palliative Radiotherapy for Oncologic Emergencies in the setting of COVID-19: Approaches to Balancing Risks and Benefits AAPM medical physics practice guideline 10.a.: Scope of practice for clinical medical physics EFOMP policy statement 16: The role and competences of medical physicists and medical physics experts under 2013/59/EURATOM Position of the AIFM in optimization of medical/health physics resources in the light of the SARS COVID-19 crisis (in Italian) The European Federation of Medical Physics Organizations (EFOMP), COVID-19 virus -EFOMP President's message Telecommuting: a viable option for Medical Physicists amid the COVID-19 outbreak and beyond The report of Task Group 100 of the AAPM: Application of risk analysis methods to radiation therapy quality management Acknowledgements: All authors would like to acknowledge useful discussions with other colleagues at their respective institutions. The authors are grateful to the referee for his/her valuable comments which improved the quality of the manuscript.